Vaccination with agonist peptide PSA: 154-163 (155L) derived from prostate specific antigen induced CD8 T-cell response to the native peptide PSA: 154-163 but failed to induce the reactivity against tumor targets expressing PSA: a phase 2 study in p

Vaccination with agonist peptide PSA: 154-163 (155L) derived from prostate specific antigen induced CD8 T-cell response to the native peptide PSA: 154-163 but failed to induce the reactivity against tumor targets expressing PSA: a phase 2 study in p

Item
http://www.wikidata.org/entity/Q37379219
Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1.Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the artImmunotherapy of human cancers using gene modified T lymphocytes.A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancerTrial watch: Peptide vaccines in cancer therapyDNA vaccines for the treatment of prostate cancer.Immunological therapy in urological malignancy: novel combination strategies.Ultrasound-based combination therapy: potential in urologic cancer.DNA fusion gene vaccines induce cytotoxic T-cell attack on naturally processed peptides of human prostate-specific membrane antigen.HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.
P2860

Vaccination with agonist peptide PSA: 154-163 (155L) derived from prostate specific antigen induced CD8 T-cell response to the native peptide PSA: 154-163 but failed to induce the reactivity against tumor targets expressing PSA: a phase 2 study in p

Item
http://www.wikidata.org/entity/Q37379219
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vaccination with agonist pepti ...... sing PSA: a phase 2 study in p
@en
Vaccination with agonist peptide PSA: 154-163
@nl
type
label
Vaccination with agonist pepti ...... sing PSA: a phase 2 study in p
@en
Vaccination with agonist peptide PSA: 154-163
@nl
prefLabel
Vaccination with agonist pepti ...... sing PSA: a phase 2 study in p
@en
Vaccination with agonist peptide PSA: 154-163
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Vaccination with agonist pepti ...... sing PSA: a phase 2 study in p
@en
P2093
P2860
P304
P31
P356
10.1097/CJI.0B013E3181A80E0D
P433
P478
P577
P5875
P698
P932